Evidence map›Paper›PMID 28961426›Full record

ArticleCarbohydrate research2017

Chemoenzymatic synthesis of Neu5Ac9NAc-containing α2-3- and α2-6-linked sialosides and their use for sialidase substrate specificity studies.

Wanqing Li, An Xiao, Yanhong Li, Hai Yu, Xi Chen

Open access · greenAbstract read
In one paragraph

Article in Carbohydrate research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Chemoenzymatic Synthesis ofTetrahedron · 2023
    Article
  7. Sialosides Containing 7-ACS infectious diseases · 2023
    Article
  8. Article
  9. Chemoenzymatic Synthesis of Sialosides Containing 7-The Journal of organic chemistry · 2021
    Article
  10. Article
  11. Review
  12. A Chemoenzymatic Synthon Strategy for SynthesizingThe Journal of organic chemistry · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Wanqing LiDepartment of Chemistry, University of California-Davis, One Shields Avenue, Davis, CA 95616, USA.
An XiaoDepartment of Chemistry, University of California-Davis, One Shields Avenue, Davis, CA 95616, USA.
Yanhong LiDepartment of Chemistry, University of California-Davis, One Shields Avenue, Davis, CA 95616, USA.
Hai YuDepartment of Chemistry, University of California-Davis, One Shields Avenue, Davis, CA 95616, USA.
Xi ChenDepartment of Chemistry, University of California-Davis, One Shields Avenue, Davis, CA 95616, USA. Electronic address: xiichen@ucdavis.edu.
University of California, Davis · US

Funding

Facile chemoenzymatic synthesis and purification of glycolipidsU01GM120419 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CHEN, XI · 2016 to 2019
$2.8M
NIGMS NIH HHS U01 GM120419
6 · The paper itself

Abstract

O-Acetylation of sialic acid (Sia) modulates its recognition by sialic acid-binding proteins and plays an important role in biological and pathological processes. 9-O-Acetylation is the most common modification of sialic acid in human. However, study of O-acetylated sialoglycans is hampered due to the instability of O-acetyl group towards pH changes and sensitivity to esterases. Our previous studies demonstrated a chemical biology method to this problem by replacing the oxygen atom in the C9 ester group of sialic acid by a nitrogen to form an amide. Here, we synthesized a library of sixteen new 9-acetamido-9-deoxy-N-acetylneuraminic acid (Neu5Ac9NAc)-containing α2-3- and α2-6-linked sialosides with various underlying glycans using efficient one-pot three-enzyme (OP3E) sialylation systems. Neu5Ac9NAc-containing compounds with a para-nitrophenol aglycon have been used together with their 9-O-acetyl analogs in microtiter plate-based high-throughput substrate specificity studies of nine different sialidases including those from humans and bacteria. In general, similar to 9-O-acetylation, 9-N-acetyl modification of sialic acid in the substrates lowers sialic acid-cleavage activity of most sialidases. In most cases, Neu5Ac9NAc is a good analog of 9-O-acetyl sialic acid. However, exceptions do exist. For example, 9-N- and 9-O-acetyl modifications have different effects on the sialosides cleave efficiencies of a commercially available C. perfringens sialidase as well as recombinant Streptococcus pneumoniae sialidase SpNanC and Bifidobacterium infantis sialidase BiNanH2. The mechanism for the difference awaits further investigation.

Indexed as

GlycosidesMolecular StructureN-Acetylneuraminic AcidNeuraminidaseSubstrate SpecificityGlycosidesN-Acetylneuraminic AcidNeuraminidase9-N-acetyl sialic acid9-O-acetyl sialic acidChemoenzymatic synthesisOne-pot multienzymeSialic acid

Identifiers

PMID28961426
PMCPMC5662470
OpenAlexW2754440214

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.